KINNATE BIOPHARMA INC's ticker is KNTE and the CUSIP is 49705R105. A total of 73 filers reported holding KINNATE BIOPHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,809,963 | +495.7% | 1,089,594 | +481.4% | 0.09% | +520.0% |
| Q4 2022 | $1,143,128 | -81.8% | 187,398 | -64.3% | 0.02% | -83.0% |
| Q3 2022 | $6,270,000 | +91.0% | 524,669 | +101.6% | 0.09% | +72.5% |
| Q2 2022 | $3,282,000 | +12.0% | 260,276 | 0.0% | 0.05% | +6.2% |
| Q1 2022 | $2,931,000 | -36.4% | 260,276 | 0.0% | 0.05% | -27.3% |
| Q4 2021 | $4,612,000 | -23.0% | 260,276 | 0.0% | 0.07% | -32.7% |
| Q3 2021 | $5,992,000 | -1.1% | 260,276 | 0.0% | 0.10% | -13.3% |
| Q2 2021 | $6,059,000 | -32.0% | 260,276 | -9.0% | 0.11% | -42.9% |
| Q1 2021 | $8,916,000 | -18.9% | 286,129 | +3.5% | 0.20% | -32.2% |
| Q4 2020 | $10,997,000 | – | 276,451 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 9,671,643 | $225,156,000 | 30.44% |
| Vida Ventures Advisors, LLC | 2,747,433 | $63,960,000 | 16.04% |
| Foresite Capital Management V, LLC | 875,001 | $20,370,000 | 8.01% |
| VR Adviser, LLC | 1,473,014 | $34,292,000 | 4.16% |
| Logos Global Management LP | 1,329,602 | $30,953,000 | 2.60% |
| RA Capital Management | 3,593,052 | $83,646,000 | 1.34% |
| Orbimed Advisors | 3,847,929 | $89,580,000 | 0.91% |
| Boxer Capital, LLC | 1,065,939 | $24,815,000 | 0.88% |
| HARVARD MANAGEMENT CO INC | 498,001 | $11,593,000 | 0.67% |
| HighVista Strategies LLC | 33,391 | $777,000 | 0.55% |